Drug Trial Radar · NCT05509153
A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
Last checked: Nov 20, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Jun 1, 2024
Primary completion
Nov 1, 2026
Study completion May 1, 2027
Sponsor
- Lead sponsor
- Western Sydney Local Health DistrictAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Deakin University; Monash University; Royal Perth Hospital; The University of Queensland; University of Melbourne
- First posted
- Aug 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
NAC-preHD is a phase II randomized placebo controlled study of oral NAC among premanifest HD gene expansion carriers, with clinical and radiological outcome at three years.
Conditions
- Huntington Disease
Interventions
NACDrug
1g of clinical grade N-Acetylcysteine capsules, taken orally twice a day
PlaceboDrug
Coated Placebo capsules, manufactured to match appearance and taste, taken orally twice a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Caudate Atrophy Rate on volumetric MRITime frame: Baseline through end of study (up to 3 years)
- Rate of motor phenoconversionTime frame: Baseline through end of study (up to 3 years)
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Westmead Hospital
Westmead, New South Wales, Australia · Recruiting
The University of Queensland
Herston, Queensland, Australia · Not yet recruiting
Calvary Health Care Bethlehem
Parkdale, Victoria, Australia · Not yet recruiting
The Royal Melbourne Hospital
Parkville, Victoria, Australia · Not yet recruiting
Perron Institute
Nedlands, Western Australia, Australia · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.